EUVIMEDEUVIMED entdecken
Open Access

Macromolecular crowding inhibits degradation of alpha‐synuclein amyloid fibrils induced by cathepsins and MMP9

Maksim I Sulatsky, Olesya V Stepanenko, Olga V Stepanenko, Ekaterina V Mikhailova, Anna I Sulatskaya

Protein Science · 2026-07 · 35 (7)

DOI: 10.1002/pro.70707 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein Science, online erschienen am 23.06.2026. Verfasst von Maksim I Sulatsky und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cell Morphology, Institute of Cytology Russian Academy of Sciences, St. Petersburg, Russia. Hauptthemen laut MEDLINE: alpha-Synuclein, Amyloid, Matrix Metalloproteinase 9, Cathepsin D. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The accumulation of amyloid fibrils in the brain leads to cognitive and motor impairment in incurable neurodegenerative disorders, particularly in Alzheimer's and Parkinson's diseases. Emerging anti‐amyloid immunotherapies rely on recruiting immune proteases to clear these pathological aggregates, yet a stark disconnect remains between the high proteolytic efficiency observed in dilute in vitro assays and the limited efficacy of these treatments in vivo. This discrepancy likely arises because standard models neglect the dense macromolecular crowding characteristic of the cellular milieu. Here, we address this gap by investigating the degradation of alpha‐synuclein amyloids by key immune proteases (cathepsin B, cathepsin D, and matrix metalloproteinase‐9) in the presence of synthetic crowding agents at physiological densities. We found that macromolecular crowding in a crowding agent‐ and dose‐dependent manner inhibits protease‐induced amyloid declusterization, cluster size reduction, fibril fragmentation, and structural disorganization. We propose that the observed inhibition arises from the excluded volume effect, which stabilizes fibril structure and restricts both enzyme mobility and steric access to the fibril surface rather than suppressing catalytic activity. By restricting the extent of enzymatic amyloid degradation, this “crowding shield” modulated the cytotoxic consequences of enzymatic processing in human cell lines, attenuating enzyme‐induced shifts in fibril toxicity in a condition‐dependent manner. These findings identify the crowded cellular environment as a critical stabilizer of pathogenic protein aggregates, explaining their persistence in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinAmyloidMatrix Metalloproteinase 9Cathepsin DCathepsin BHumansProteolysis

Stichwörter der Autor:innen

alpha‐synucleinamyloid clearanceamyloid fibrilscathepsin Bcathepsin Dexcluded volume effectmacromolecular crowdingmatrix metalloproteinase‐9proteolysis

Substanzen

alpha-SynucleinAmyloidMatrix Metalloproteinase 9MMP9 protein, humanCathepsin DCathepsin B

Autor:innen und Institutionen

  • Laboratory of Cell Morphology, Institute of Cytology Russian Academy of Sciences, St. Petersburg, Russia.
  • Laboratory of Structural Dynamics, Stability and Folding of Proteins, Institute of Cytology Russian Academy of Sciences, St. Petersburg, Russia.

Förderung

  • Russian Science Foundation

Zitieren

APA

Sulatsky, M. I., Stepanenko, O. V., Stepanenko, O. V., Mikhailova, E. V., & Sulatskaya, A. I. (2026). Macromolecular crowding inhibits degradation of alpha‐synuclein amyloid fibrils induced by cathepsins and MMP9. Protein Science, 35(7). https://doi.org/10.1002/pro.70707

Vancouver

Sulatsky MI, Stepanenko OV, Stepanenko OV, Mikhailova EV, Sulatskaya AI. Macromolecular crowding inhibits degradation of alpha‐synuclein amyloid fibrils induced by cathepsins and MMP9. Protein Science. 2026;35(7). doi:10.1002/pro.70707

BibTeX
@article{Sulatsky2026,
  author = {Sulatsky, Maksim I and Stepanenko, Olesya V and Stepanenko, Olga V and Mikhailova, Ekaterina V and Sulatskaya, Anna I},
  title = {Macromolecular crowding inhibits degradation of alpha‐synuclein amyloid fibrils induced by cathepsins and MMP9},
  journal = {Protein Science},
  year = {2026},
  volume = {35},
  number = {7},
  doi = {10.1002/pro.70707}
}
Kostenlos starten →